CNBC Top Stories

The obesity approval further establishes Eli Lilly as a formidable competitor to Novo Nordisk in the budding weight loss drug industry.

Nikki Haley could see a wave of undecided wealthy donors get off the sidelines and support her after the third Republican debate.

After FTX founder Sam Bankman-Fried was found guilty of fraud charges last week, SEC chair Gary Gensler said the crypto exchange could be revived.

Snap has conducted a round of layoffs impacting 20 product managers as part of a reorganization intended to streamline the social-messaging company.

Artificial intelligence ETFs are giving investors a way to trade beyond the traditional tech names.

A network of pricey brothels around Boston and eastern Virginia provided politicians, doctors and others with sex for pay, according to a bombshell complaint.

Polestar said it is targeting a gross profit margin in the high teens, and deliveries of 155,000 to 165,000 vehicles, in 2025.

Rocket Lab's launch business saw $21.3 million in revenue in the third quarter, with a mid-September mission failure halting the company's momentum.

Ivanka was the latest Trump to testify as part of James' case accusing Trump Sr., his adult sons and others of fraudulently inflating asset values.

A lot is riding on Disney's earnings report as Peltz and his firm, Trian, weigh a possible proxy fight.

Warner Bros. Discovery reported third quarter earnings before the bell Wednesday.

Satellite imagery venture BlackSky delivered its first quarterly profit Wednesday, as the company works to keep up momentum into the end of the year.

Roblox shares jumped Wednesday after the company released third-quarter results that beat analysts' estimates.

Take-Two Interactive shares surged as much as 9.4% in premarket trading Wednesday, in anticipation of a full announcement for its Grand Theft Auto 6 game.

The labyrinth of tunnels offer Hamas a strategic advantage to shield and ambush Israeli ground infantry, as well as move and store weapons and explosives.

Social Security's funds may run out in the next decade, when 80% of benefits will be payable. Implementing certain changes now may help, a new report finds.

Shares of Eli Lilly jumped Wednesday after the U.S. gave the green light for the company's blockbuster GLP-1 drug to be used as an obesity treatment.

The agreement averts a walkout by 10,000 Caesars employees on the Las Vegas strip.

Over the past two decades, no stock in the S&P 500 has posted a higher return than energy drink firm Monster Beverage.

There's a loophole for parent borrowers shut out of student loan relief measures, but it's complicated, experts caution.